We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
+10.57%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$149M
Cap. Flow
+$21.3M
Cap. Flow %
1.41%
Top 10 Hldgs %
42.95%
Holding
104
New
3
Increased
64
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$12.9M
2
SNOW icon
Snowflake
SNOW
+$10M
3
ADPT icon
Adaptive Biotechnologies
ADPT
+$5.7M
4
OGN icon
Organon & Co
OGN
+$1.9M
5
MSFT icon
Microsoft
MSFT
+$1.41M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$16.1M
2
AYX
Alteryx Inc
AYX
+$6.07M
3
QRVO icon
Qorvo
QRVO
+$3.5M
4
MRK icon
Merck
MRK
+$2.06M
5
GTLS
Chart Industries
GTLS
+$610K

Sector Composition

Rank Sector Weight
1 Technology 30.49%
2 Healthcare 20.63%
3 Consumer Discretionary 12.82%
4 Industrials 11.64%
5 Financials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICE icon
51
Intercontinental Exchange
ICE
$82.4B
$6.15M 0.41%
51,779
+3,305
+7% +$380K
HON icon
52
Honeywell
HON
$77.1B
$6.13M 0.4%
29,655
+1,742
+6% +$368K
CI icon
53
Cigna
CI
$76.6B
$6.1M 0.4%
25,728
-64,283
-71% -$16.1M
ABT icon
54
Abbott
ABT
$180B
$5.78M 0.38%
49,855
+2,869
+6% +$334K
SWKS icon
55
Skyworks Solutions
SWKS
$9.06B
$5.74M 0.38%
29,936
+1,784
+6% +$317K
AVY icon
56
Avery Dennison
AVY
$12.3B
$5.71M 0.38%
27,134
+1,731
+7% +$364K
MUSA icon
57
Murphy USA
MUSA
$11.3B
$5.59M 0.37%
41,913
– –
PSX icon
58
Phillips 66
PSX
$82.9B
$5.57M 0.37%
64,857
+4,028
+7% +$340K
CB icon
59
Chubb
CB
$140B
$5.4M 0.36%
34,000
+2,174
+7% +$360K
EL icon
60
Estee Lauder
EL
$29B
$5.29M 0.35%
16,648
+1,065
+7% +$323K
TT icon
61
Trane Technologies
TT
$106B
$5.01M 0.33%
27,195
+1,736
+7% +$309K
BDX icon
62
Becton Dickinson
BDX
$43.1B
$4.93M 0.33%
20,781
+1,263
+6% +$303K
MCHP icon
63
Microchip Technology
MCHP
$42.8B
$4.81M 0.32%
64,206
+4,080
+7% +$311K
ORLY icon
64
O'Reilly Automotive
ORLY
$72.4B
$4.46M 0.29%
118,245
+7,530
+7% +$270K
CTLT
65
DELISTED
CATALENT, INC.
CTLT
$4.45M 0.29%
41,112
+2,522
+7% +$270K
GM icon
66
General Motors
GM
$74.7B
$4.02M 0.27%
67,977
+4,332
+7% +$255K
PEP icon
67
PepsiCo
PEP
$186B
$3.87M 0.26%
26,117
+1,664
+7% +$242K
GTLS
68
DELISTED
Chart Industries
GTLS
$3.6M 0.24%
24,591
-4,156
-14% -$610K
DG icon
69
Dollar General
DG
$25.9B
$3.41M 0.23%
15,764
+999
+7% +$210K
NEE icon
70
NextEra Energy
NEE
$187B
$3.22M 0.21%
43,904
+2,788
+7% +$209K
ARE icon
71
Alexandria Real Estate Equities
ARE
$8.88B
$3.06M 0.2%
16,827
+1,072
+7% +$192K
NOW icon
72
ServiceNow
NOW
$102B
$3.05M 0.2%
27,765
+150
+0.5% +$15.2K
TEL icon
73
TE Connectivity
TEL
$58.8B
$2.7M 0.18%
20,000
– –
ILMN icon
74
Illumina
ILMN
$29.4B
$2.6M 0.17%
5,654
– –
IFF icon
75
International Flavors & Fragrances
IFF
$19.4B
$2.46M 0.16%
16,466
– –
1 2
3
4 5

Similar funds

SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Aristotle Atlantic Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Aristotle Atlantic Partners held 104 positions worth $1.52B, up 11% from $1.37B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Aristotle Atlantic Partners's Q2 2021 filing shows 3 new, 64 increased, 4 reduced and 3 closed positions. Its largest new stake was Vertex Pharmaceuticals: 61,548 shares worth $12.4M. The largest sale was Cigna, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aristotle Atlantic Partners's largest Q2 2021 buy was Vertex Pharmaceuticals: 61,548 shares worth $12.4M.
  • Aristotle Atlantic Partners added most to Adaptive Biotechnologies in Q2 2021, an estimated $5.7M increase.
  • Aristotle Atlantic Partners's biggest Q2 2021 reduction was Cigna, cutting an estimated $16.1M.
  • Aristotle Atlantic Partners fully exited Alteryx Inc in Q2 2021, selling an estimated $6.07M.
  • Aristotle Atlantic Partners's ten largest holdings make up 43% of its $1.52B portfolio in Q2 2021.
  • Aristotle Atlantic Partners opened 3 new positions and closed 3 in Q2 2021.
  • Aristotle Atlantic Partners's portfolio value rose 11% quarter-over-quarter to $1.52B.

Based on Aristotle Atlantic Partners's 13F filing for Q2 2021, filed 16 Aug 2021.